BioCardia, Inc.BCDANASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P10
Near historical low
vs 5Y Ago
-2.8x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -31.87% |
| Q2 2025 | -10.59% |
| Q1 2025 | 8.13% |
| Q4 2024 | 51.99% |
| Q3 2024 | 16.38% |
| Q2 2024 | -35.54% |
| Q1 2024 | 7.35% |
| Q4 2023 | -38.25% |
| Q3 2023 | -19.10% |
| Q2 2023 | -2.94% |
| Q1 2023 | 8.36% |
| Q4 2022 | 2.61% |
| Q3 2022 | -6.94% |
| Q2 2022 | 5.40% |
| Q1 2022 | 3.36% |
| Q4 2021 | -5.58% |
| Q3 2021 | -5.17% |
| Q2 2021 | 28.30% |
| Q1 2021 | -20.82% |
| Q4 2020 | -6.02% |
| Q3 2020 | 11.24% |
| Q2 2020 | -20.17% |
| Q1 2020 | 28.39% |
| Q4 2019 | 8.12% |
| Q3 2019 | -9.55% |
| Q2 2019 | 2.45% |
| Q1 2019 | -1.77% |
| Q4 2018 | -2.52% |
| Q3 2018 | 11.37% |
| Q2 2018 | 3.89% |
| Q1 2018 | 10.39% |
| Q4 2017 | 4.18% |
| Q3 2017 | 31.27% |
| Q2 2017 | 25.36% |
| Q1 2017 | -39.52% |
| Q4 2016 | 149.71% |
| Q3 2016 | 37.63% |
| Q2 2016 | 12.70% |
| Q1 2016 | 102.29% |
| Q4 2015 | -49.54% |